Mojca Božič Mijovski

Author

Ljubljana University Medical Centre ORCID

Also Known As

Aleš Blinc, Ana Mavric, Anamarija Zega, M Bozic, M Bozic Mijovski, M Bozić, M Božic, M. Bozic, M. Bozic Mijovski, M. Bozic-Mijovski

107

Publications

Citations

H-Index

Concepts

All Affiliations

Ljubljana University Medical Centre University of Ljubljana Karolinska Institutet Karolinska University Hospital Krka (Slovenia)

About

Mojca Božič Mijovski is an author at Ljubljana University Medical Centre specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	336
2	Public Health	5	5	160
3	Biomedical Engineering	2	2	57
4	Emergency Medicine	2	2	63
5	Engineering	1	1	42

Mojca Božič Mijovski

Publications

714

Citations

H-Index

Page 1

	Year	Citations
D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis Mojca Božič Mijovski, Aleš Blinc, Mojca Stegnar Thrombosis Research ThrombopoiesisThrombosisSoluble Adhesion MoleculesVenous ThrombosisCardiovascular Disease	2002	58
Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers Pavel Poredoš, Ana Spirkoska, Luka Ležaić, Journal of Atherosclerosis and Thrombosis	2016	49
Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation Marko Miklič, Alenka Mavri, Nina Vene, European Journal of Clinical Pharmacology ThrombosisPotential Bleeding RiskCardiovascular DiseaseFibrinolysisCoagulopathy	2019	44
Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors Irena Keber, Branka Žegura, Saša Simčič, Thrombosis and Haemostasis	2004	42
Methyl-methacrylate bone cement surface does not promote platelet aggregation or plasma coagulation in vitro Aleš Blinc, Mojca Božič Mijovski, Rok Vengust, Thrombosis Research Tissue EngineeringThrombosisThrombopoiesisPlasma CoagulationEngineering	2004	42
Dabigatran Concentration: Variability and Potential Bleeding Prediction In “Real-Life” Patients With Atrial Fibrillation Petra Šinigoj, Rickard E. Malmström, Nina Vene, Basic & Clinical Pharmacology & Toxicology Cardiovascular PharmacologyPharmacotherapyDabigatran TroughThrombosisHematology	2015	42
Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations Mojca Božič Mijovski, Rickard E. Malmström, Petra Malovrh, Annals of Clinical Biochemistry International Journal of Laboratory Medicine	2015	33
Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia Saša Anžej, Mojca Božič Mijovski, Aleksandra Antovič, Thrombosis Research ThrombosisIschemic StrokeCardiovascular DiseaseAtherosclerosisMedicine	2006	32
Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation Alenka Mavri, Nina Vene, Mojca Božič Mijovski, Scientific Reports	2021	32
Factor V Leiden, prothrombin 20210G → A, methylenetetrahydrofolate reductase 677C → T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism Leon Meglič, Mojca Stegnar, Tomaž Milanez, European Journal of Obstetrics & Gynecology and Reproductive Biology ThrombopoiesisThrombosisVenous DiseaseVenous ThrombosisMaternal Cardiovascular Outcome	2003	30

Page 1